Skip to Content
Merck
CN

SML3534

Laninamivir octanoate

≥98% (HPLC)

Synonym(s):

3-(O)-octanoyl R 125489, 3-(O)-octanoyl R-125489, 3-(O)-octanoyl R125489, 4S,5R,6R)-5-Acetamido-4-guanidino-6-((1R,2R)-2-hydroxy-1-methoxy-3-(octanoyloxy)propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid, 5-(Acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-7-O-methyl-D-glycero-D-galacto-non-2-enonic acid 9-octanoate, CS 8958, CS-8958, CS8958, LNO, Laninamivir prodrug

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C21H36N4O8
CAS Number:
203120-46-1
Molecular Weight:
472.53
UNSPSC Code:
12352200
NACRES:
NA.77
MDL number:
MFCD28138619

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Laninamivir octanoate, ≥98% (HPLC)

InChI

1S/C21H36N4O8/c1-4-5-6-7-8-9-16(28)32-11-14(27)18(31-3)19-17(24-12(2)26)13(25-21(22)23)10-15(33-19)20(29)30/h10,13-14,17-19,27H,4-9,11H2,1-3H3,(H,24,26)(H,29,30)(H4,22,23,25)/t13-,14+,17+,18+,19+/m0/s1

SMILES string

CCCCCCCC(OC[C@@H](O)[C@@H](OC)[C@@]1([H])[C@H](NC(C)=O)[C@@H](NC(N)=N)C=C(C(O)=O)O1)=O

InChI key

UKTIJASCFRNWCB-RMIBSVFLSA-N

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear (Warmed)

storage temp.

2-8°C

Quality Level

100

Related Categories

Biochem/physiol Actions

Laninamivir (R-125489) prodrug with improved in vivo efficacy than R-125489 and Zanamivir in a mouse influenza virus A (IAV) infection model.
Laninamivir octanoate (CS-8958) is the prodrug form of Laninamivir (R-125489), a potent inhibitor agianst the neuraminidase (NA) activities of various type A and B influenza viruses, including subtypes N1 to N9 and Oseltamivir-resistant strains. When administered intranasally (3X 0.2 μmol/kg; 4 h before, 4 h & 18 h post infection), CS-8958 shows improved in vivo efficacy (100% survival rate on day 20 post infecfion) than R-125489 (100/30/20% survival rate on day 7/10/20 post infecfion) and Zanamivir (100%/0% death on day 7/10) in a mouse influenza virus A/Puerto Rico/8/34 infection model, with prolonged survival effect post a single dosage given even 7 days before infection. Note: Laninamivir octanoate is mainly used for in vivo studies, it exhibits only weak to little antiviral potency before it is converted to the active drug form.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000205583
0000205584
0000198039
0000198039
0000205584

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service